Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02353000 : Whole Brain Radiotherapy (WBRT) Versus Stereotactic Radiosurgery (SRS) for 4 Upto 10 Brain Metastases
PhaseN/A
AgesMin: 18 Years Max: N/A
Eligibility
Inclusion Criteria:

- Minimal 4 up to a maximum of 10 BM on diagnostic MRI scan

- Max diameter of single GTV 2.5cm

- Max cumulative GTV of 30cm3

- Karnofsky performance status ? 70

- Any solid primary tumour. Small cell lung carcinoma, germinoma, and lymphoma are
excluded

- Ability to provide written informed consent

Exclusion Criteria:

- Contra-indication for MRI

- Prior treatment for BM (i.e. surgery, SRS or WBRT)

- Concurrent use of systemic therapy

- Maximum cumulative GTV of more than 30cm3 on planning-MRI

- More than 10 BM on planning-MRI

- A brainstem metastasis with a PTV of more than 20 cm3
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02353000      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2018 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740